{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:33:44Z","timestamp":1791977624380,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Cancer Institute Intramural Research Program"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473415"],"award-info":[{"award-number":["81473415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373040"],"award-info":[{"award-number":["81373040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004311","name":"Shanxi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bcp.2016.08.021","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T06:40:17Z","timestamp":1472625617000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4"],"prefix":"10.1016","volume":"119","author":[{"given":"Xiaoxia","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Yagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher W.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.08.021_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-5347(01)66596-0","article-title":"Flutamide hepatotoxicity","volume":"155","author":"Wysowski","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.bcp.2016.08.021_b0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pds.1168","article-title":"Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system","volume":"15","author":"Manso","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.bcp.2016.08.021_b0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000081585","article-title":"Hepatotoxicity induced by antiandrogens: a review of the literature","volume":"73","author":"Thole","year":"2004","journal-title":"Urol. Int."},{"key":"10.1016\/j.bcp.2016.08.021_b0020","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1124\/dmd.108.021725","article-title":"Covalent binding and tissue distribution\/retention assessment of drugs associated with idiosyncratic drug toxicity","volume":"36","author":"Takakusa","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.08.021_b0025","unstructured":"K.J. Coe, Metabolism and Cytotoxicity of the Nitroaromatic Drug Flutamide and Its Cyano Analog in Hepatocyte Cell Lines, ProQuest2008."},{"key":"10.1016\/j.bcp.2016.08.021_b0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.toxlet.2013.10.039","article-title":"AhR signalling and dioxin toxicity","volume":"230","author":"Sorg","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2016.08.021_b0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/toxsci\/kfp308","article-title":"Differential gene regulation by the human and mouse aryl hydrocarbon receptor","volume":"114","author":"Flaveny","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2016.08.021_b0040","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1124\/mol.106.032748","article-title":"Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro","volume":"71","author":"Hu","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.021_b0045","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1515\/bc.2010.128","article-title":"An introduction to the molecular basics of aryl hydrocarbon receptor biology","volume":"391","author":"Abel","year":"2010","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bcp.2016.08.021_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0304-4165(02)00485-3","article-title":"Functional role of AhR in the expression of toxic effects by TCDD","volume":"1619","author":"Mimura","year":"2003","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"10.1016\/j.bcp.2016.08.021_b0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bcp.2008.04.005","article-title":"Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements","volume":"76","author":"Yoshinari","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.021_b0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/taap.1996.0210","article-title":"Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity","volume":"140","author":"Fernandez-Salguero","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2016.08.021_b0065","doi-asserted-by":"crossref","first-page":"17767","DOI":"10.1074\/jbc.M209594200","article-title":"Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor","volume":"278","author":"Bunger","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.08.021_b0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1124\/jpet.112.195339","article-title":"Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells","volume":"343","author":"Jin","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.08.021_b0075","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1124\/dmd.105.009159","article-title":"Profiling the hepatic effects of flutamide in rats: a microarray comparison with classical aryl hydrocarbon receptor ligands and atypical cyp1a inducers","volume":"34","author":"Coe","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.08.021_b0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.7732381","article-title":"Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor","volume":"268","author":"Fernandez-Salguero","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.08.021_b0085","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2016.08.021_b0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.bcp.2016.08.021_b0095","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1074\/jbc.271.7.3743","article-title":"Identification of a novel domain in the aryl hydrocarbon receptor required for DNA binding","volume":"271","author":"Fukunaga","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.08.021_b0100","article-title":"The aryl hydrocarbon receptor complex and the control of gene expression, Critical Reviews\u2122 in Eukaryotic","volume":"18","author":"Beischlag","year":"2008","journal-title":"Gene Expr."},{"key":"10.1016\/j.bcp.2016.08.021_b0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/tx7001965","article-title":"The search for endogenous activators of the aryl hydrocarbon receptor","volume":"21","author":"Nguyen","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2016.08.021_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.pa.35.040195.001515","article-title":"The aryl hydrocarbon receptor complex","volume":"35","author":"Hankinson","year":"1995","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2016.08.021_b0115","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1021\/jm900199u","article-title":"Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands","volume":"52","author":"Bisson","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2016.08.021_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/prot.340230314","article-title":"Homology modeling by the ICM method","volume":"23","author":"Cardozo","year":"1995","journal-title":"Proteins Struct. Funct. Bioinf."},{"key":"10.1016\/j.bcp.2016.08.021_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1099-1352(199905\/06)12:3<177::AID-JMR451>3.0.CO;2-Z","article-title":"Prediction of the binding energy for small molecules, peptides and proteins","volume":"12","author":"Schapira","year":"1999","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bcp.2016.08.021_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2016.08.021_b0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0002-9343(92)90741-S","article-title":"Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients","volume":"92","author":"Gomez","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcp.2016.08.021_b0140","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0140-6736(06)68498-5","article-title":"Fatal liver complications with flutamide","volume":"367","author":"Osculati","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2016.08.021_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.abb.2008.01.014","article-title":"The mouse and human Ah receptor differ in recognition of LXXLL motifs","volume":"471","author":"Flaveny","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2016.08.021_b0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-3565(24)38762-2","article-title":"Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?","volume":"296","author":"Rochat","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.08.021_b0155","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0022-3565(25)38899-3","article-title":"Toxicity of the antiandrogen flutamide in isolated rat hepatocytes","volume":"269","author":"Fau","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.08.021_b0160","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/dmd.107.014860","article-title":"Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes","volume":"35","author":"Kang","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.08.021_b0165","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1124\/dmd.108.020370","article-title":"Bioactivation of flutamide metabolites by human liver microsomes","volume":"36","author":"Kang","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.08.021_b0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cbi.2013.04.002","article-title":"Dehydroepiandrosterone post-transcriptionally modifies CYP1A2 induction involving androgen receptor","volume":"203","author":"Belic","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2016.08.021_b0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21671","article-title":"Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver","volume":"46","author":"Patel","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2016.08.021_b0180","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1248\/bpb.30.739","article-title":"Involvement of bile salt export pump in flutamide-induced cholestatic hepatitis","volume":"30","author":"Iwanaga","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bcp.2016.08.021_b0185","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1194\/jlr.D028803","article-title":"Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method","volume":"53","author":"Garcia-Canaveras","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2016.08.021_b0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.abb.2004.09.019","article-title":"Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism","volume":"433","author":"Eloranta","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2016.08.021_b0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2016.08.021_b0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2016.08.021_b0205","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2016.08.021_b0210","doi-asserted-by":"crossref","first-page":"G640","DOI":"10.1152\/ajpgi.00354.2005","article-title":"Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione","volume":"290","author":"Rius","year":"2006","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"key":"10.1016\/j.bcp.2016.08.021_b0215","doi-asserted-by":"crossref","first-page":"G126","DOI":"10.1152\/ajpgi.00522.2010","article-title":"Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression","volume":"299","author":"Xu","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2016.08.021_b0220","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1124\/dmd.112.045112","article-title":"Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARalpha-, and Nrf2-null mice","volume":"40","author":"Aleksunes","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.08.021_b0225","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2016.08.021_b0230","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/03602530903492004","article-title":"Role of the bile salt export pump, BSEP, in acquired forms of cholestasis","volume":"42","author":"Stieger","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2016.08.021_b0235","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1289\/ehp.1409055","article-title":"Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation","volume":"123","author":"Zhang","year":"2015","journal-title":"Environ. Health Perspect."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216302581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216302581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:43:47Z","timestamp":1749570227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216302581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":47,"alternative-id":["S0006295216302581"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.08.021","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}